Bio-Rad Laboratories (BIO) Gains from Investment Securities (2013 - 2017)
Bio-Rad Laboratories' (BIO) quarterly Gains from Investment Securities came in at -$3.0 million in Q3 2017, down 939.18% year-over-year from $360353.8 in Q3 2016, and down 532.0% quarter-over-quarter from $700000.0 in Q2 2017.
Powered by 
Analysis
Bio-Rad Laboratories (BIO) Gains from Investment Securities (2013 - 2017) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported Gains from Investment Securities for 5 consecutive years, with -$3.0 million the latest figure, recorded in Q3 2017.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2017 | -3.02 Mn |
| Jun 30, 2017 | 700,000.00 |
| Mar 31, 2017 | -9.40 Mn |
| Sep 30, 2016 | -291,000.00 |
| Jun 30, 2016 | -589,000.00 |
| Mar 31, 2016 | -1.28 Mn |
| Sep 30, 2015 | -825,000.00 |
| Jun 30, 2015 | 1.29 Mn |
| Mar 31, 2015 | -1.19 Mn |
| Sep 30, 2014 | -3.04 Mn |
| Jun 30, 2014 | -446,000.00 |
| Mar 31, 2014 | -4.89 Mn |
| Sep 30, 2013 | -46,000.00 |
| Jun 30, 2013 | -590,000.00 |
| Mar 31, 2013 | -711,000.00 |